Literature DB >> 22426564

Risk factors for metabolic syndrome in a cohort study in a north China urban middle-aged population.

Mark A Strand1, Judy Perry2, Ping Wang3, Shuangfeng Liu3, Henry Lynn4.   

Abstract

As China undergoes urbanization, lifestyles and disease profiles are changing. In this study, metabolic syndrome (MetS) was discovered in 53.5% and 42.7% of men and women, respectively. In 3 age cohorts (44, 48, and 52 years), prevalence of MetS among women was 33.3%, 41.4%, and 50.8%, respectively (χ(2) = 10.27, P = .006), whereas among men it was 51.5%, 56.3%, and 52.3%, respectively (χ(2) = 0.46, P = .796). The component contributing to the presence of MetS was increased waist circumference, especially among women. MetS among men results from higher rates of elevated triglycerides, blood pressure, and blood glucose when compared with women. Risk factors for MetS included less than 60 minutes of exercise a week (odds ratio [OR] = 1.7, 95% confidence interval [CI] = 1.3-2.4) and rarely consuming milk (OR = 1.7, 95% CI = 1.2-2.3). Abstaining from or occasionally consuming alcohol (OR = 0.7, 95% CI = 0.4-1.1) and having parents with no chronic disease (OR = 0.4, 95% CI = 0.2-0.6) suggest increased protection against MetS.
© 2012 APJPH.

Entities:  

Keywords:  dyslipidemia; metabolic syndrome; noncommunicable diseases; primary health care; waist circumference

Mesh:

Substances:

Year:  2012        PMID: 22426564     DOI: 10.1177/1010539512438609

Source DB:  PubMed          Journal:  Asia Pac J Public Health        ISSN: 1010-5395            Impact factor:   1.399


  2 in total

Review 1.  Meat Consumption and Risk of Metabolic Syndrome: Results from the Korean Population and a Meta-Analysis of Observational Studies.

Authors:  Youngyo Kim; Youjin Je
Journal:  Nutrients       Date:  2018-03-22       Impact factor: 5.717

2.  Dairy Consumption and Risk of Metabolic Syndrome: Results from Korean Population and Meta-Analysis.

Authors:  Shaoyue Jin; Youjin Je
Journal:  Nutrients       Date:  2021-05-08       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.